Javelin Pharma (JAV) Posts Q3 Loss of 11c, Misses Views
More News related to JAV
- Javelin Pharma (JAV) Posts Q3 Loss of 11c, Misses Views
- Javelin Pharmaceuticals, Inc. Reports Third Quarter 2009 Results
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- Javelin Pharmaceuticals to Announce Third Quarter 2009 Financial Results
- Javelin Pharmaceuticals, Inc. Tops Up Balance Sheet Through Registered Direct Offering
Javelin Pharmaceuticals Inc. (NYSE: JAV) reports Q3 loss of $0.11, versus the analyst estimate of ($0.10). Revenue for the quarter was $1,130,966, which compares to the estimate of $920,000.
Related Categories
EarningsStocks Mentioned
+0.07Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
